Recent preclinical studies have demonstrated that central GIP receptor activation can attenuate the aversive effects, such as nausea and vomiting, typically induced by GLP1 receptor agonism 29
This medication contains the active ingredient tirzepatide, which belongs to a class of drugs known as dual GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptor agonists
[1] Additionally, gastrointestinal side effectsparticularly nausea, vomiting, and diarrheasometimes lead patients to reduce doses or skip injections, inadvertently limiting efficacy
Furthermore, increased ACE2 expression in alveolar type II pneumocytes and alveolar macrophages of individuals with severe SARS-CoV-2 disease (ARDS with diffuse alveolar damage) requiring mechanical ventilation (Baker et al., 2021) favors a concomitant increase in oxidative stress in those individuals
When evaluating affordable GLP-1 choices, discussing your genetic and biomarker profile with a qualified healthcare provider can help identify which compounded formulation offers the best balance of cost and clinical potential
Learn More About Dr